The above data strongly support the idea that the CD47/SIRPα axis plays an important role in rectal cancer resistance to CRT, and that post-irradiation tumor clearance through macrophage phagocytosis can be enhanced by the therapeutic targeting of this pathway. Here, CD47 is linked to rectal cancer.